BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9784049)

  • 1. Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports).
    Kokelj F; Plozzer C; Torsello P; Trevisan G
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):177-9. PubMed ID: 9784049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A.
    Schopf RE; Hultsch T; Lotz J; Bräutigam M
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):234-9. PubMed ID: 9883435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
    Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of erythrodermic and pustulous psoriasis with a combination of methotrexate and etretinate].
    Allegue Rodriguez F; Sendagorta Gomendio E; Freire Murgueytio P; Moreno Izquierdo R; Ledo Pozueta A
    Med Cutan Ibero Lat Am; 1988; 16(1):43-9. PubMed ID: 2967409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010.
    Akasaka E; Mabuchi T; Manabe Y; Yahagi E; Yamada-Hiruma A; Yamaoka H; Kojima T; Kato M; Ikoma N; Ozawa A; Haruki Y
    J Dermatol; 2013 Apr; 40(4):238-43. PubMed ID: 23330814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A treatment in severe childhood psoriasis.
    Pereira TM; Vieira AP; Fernandes JC; Sousa-Basto A
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):651-6. PubMed ID: 16836490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of etretinate (Tigason) and parenteral gold in the treatment of psoriatic arthropathy.
    Seppälä J; Laulainen M; Reunala T
    Clin Rheumatol; 1988 Dec; 7(4):498-503. PubMed ID: 3149925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
    Aydin F; Canturk T; Senturk N; Turanli AY
    Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin in psoriasis: continuous monotherapy versus intermittent long-term therapy.
    Ozawa A; Sugai J; Ohkido M; Ohtsuki M; Nakagawa H; Kitahara H; Tamaki K; Urabe K; Nakayama J; Horikoshi T; Morimoto Y; Jimbow K
    Eur J Dermatol; 1999; 9(3):218-23. PubMed ID: 10210789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigason (etretinate) treatment in psoriatic arthritis.
    Ciompi ML; Bazzichi L; Marotta G; Pasero G
    Int J Tissue React; 1988; 10(1):25-7. PubMed ID: 3397251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis].
    Gajardo J
    Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G; Meyer-Hamme S; Ippen H
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P; Stevenson O; Berth-Jones J
    Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of cyclosporine and etretinate on serum cytokine levels in patients with psoriasis.
    Shiohara T; Imanishi K; Sagawa Y; Nagashima M
    J Am Acad Dermatol; 1992 Oct; 27(4):568-74. PubMed ID: 1401309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
    Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis.
    Moy RL; Kingston TP; Lowe NJ
    Arch Dermatol; 1985 Oct; 121(10):1297-301. PubMed ID: 3862363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis.
    Yoon HS; Youn JI
    J Dermatolog Treat; 2007; 18(5):286-90. PubMed ID: 17852632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.